BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Products » Global Database of Exosome Companies, 2021
Sale!
Exosome Companies 2020

Global Database of Exosome Companies, 2021

Category: Stem Cells Tag: exosomes
  • Description

Description

A searchable, sortable database that reveals the identities of companies worldwide developing exosome products and technologies.

Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells.

Discover class-defining bioproduction tools.

In recent years, exosomes have been gaining momentum as a strategy for accessing the therapeutic effects of cells without the risks and difficulties of administering the cells to patients. With at least 12,431 scientific articles published about exosomes and 128 clinical trials underway, these small vesicles have intriguing potential to be used within a range of therapeutic applications.

Exosomes are also coming under increasing scrutiny from  the U.S. FDA, with a Public Safety Notification on Exosome Products released December 6, 2019. As stated by the FDA: “There are currently no FDA-approved exosome products. Certain clinics across the country, including some that manufacture or market violative ‘stem cell’ products, are now also offering exosome products to patients.”

Global Database of Exosome Companies

This is a global database of exosome companies that we originally developed for our own purposes. Because more and more of our readers have been requesting access to it, we are now making it accessible.

The database features companies who are developing exosome and extracellular vesicle (EV) therapies, diagnostics and platform technologies.

The database features the following information for all known exosome market competitors, including:

  • Company Name
  • City / State
  • Country
  • Company Website
  • Type of Exosome Technology
  • Description of Exosome Technology
  • Link to Website Describing Company’s Exosome Program

Use this list of exosome companies to:

  1. Identify global competitors within the exosome marketplace
  2. Quantify exosome products in early and late stage development
  3. Identify regions that are “hotspots” for exosome therapies
  4. Understand partnerships and co-development programs for exosome technologies
  5. Identify M&A activity within the exosome industry
  6. Identify exosome companies that may or may not be in compliance with FDA Standards

Database of Exosome Companies

It takes our team of analysts hours of exhaustive research to uncover these exosome companies from across the globe.

Act now and your searchable, sortable Excel database will be available for immediate download with printing rights allowed.

Of course, your investment is backed by our 60-Day Money Back Guarantee.

4.9 / 5 ( 173 votes )

$149 $97

Related products

  • Sale!

    Exclusive 1-on-1 Interviews with Stem Cell Industry Executives

    $97 $49
    Add to cart
  • Global Induced Pluripotent Stem Cell (iPSC) Industry Report 2021

    $3,997 – $4,997
    Select options
  • Market for Stem Cell Exosomes

    The Market for Stem Cell Exosomes

    $3,495
    Add to cart
  • Sale! Regenerative medicine companies

    Regenerative Medicine Industry Database 2021 – Featuring 900+ Companies Worldwide

    $197 $97
    Add to cart

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Marathon Products

Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected
    Rated 0 out of 5
    $197
  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • BioInformant Audience Reach BioInformant's Audience with Your Press Announcement
    Rated 0 out of 5
    $397 $297
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.